Lineage Cell Therapeutics, Inc.·4

Feb 15, 7:40 PM ET

Cook Kevin Leon 4

4 · Lineage Cell Therapeutics, Inc. · Filed Feb 15, 2022

Insider Transaction Report

Form 4
Period: 2022-02-11
Cook Kevin Leon
Chief Financial Officer
Transactions
  • Award

    Restricted Stock Units

    2022-02-11+13,88813,888 total
    Common Shares (13,888 underlying)
Footnotes (2)
  • [F1]Grant of restricted stock units under Lineage's 2021 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one Common Share.
  • [F2]Subject to continuous service, vests in four equal annual installments beginning on February 11, 2023.

Documents

1 file
  • 4
    ownership.xmlPrimary